Changes in renal dimensions evaluated by magnetic resonance imaging and ultrasonography during long-term ciclosporin-A treatment

Acta Radiol. 2006 Feb;47(1):58-64. doi: 10.1080/02841850500406829.

Abstract

Purpose: To investigate changes in renal dimensions during long-term treatment with ciclosporin-A (CsA).

Material and methods: Five mini-Göttingen pigs were treated with CsA (10 mg kg(-1) day(-1)) for 6 months; 3 untreated animals served as controls. Renal length was measured by magnetic resonance imaging (MRI) and ultrasonography (US); renal volume by MRI. Examinations were performed at baseline (0 weeks) and after the start of CsA treatment at intervals of 5 weeks (5-25 weeks).

Results: Comparison of baseline and end-point data (0 weeks vs. 25 weeks) revealed a statistically significant increase in renal volume in CsA-treated animals (87.1 cm3 vs. 55.9 cm3, P=0.002). Renal volume remained unchanged in the control group. A significant increase in renal length was found both in the CsA-treated pigs (MRI: 96 mm vs. 84 mm, P<0.001; US: 94 mm vs. 81 mm, P<0.001) and in the control group (MRI: 97 mm vs. 85 mm, P<0.001; US: 89 mm vs. 81 mm, P=0.018). No difference was found between MRI and US measurements based on 40 paired units (MRI variance: 2.4-30.3% and US variance: -5.1-40.6%, P=0.133).

Conclusion: During long-term CsA treatment, renal volume increases in mini-pigs, but there is no correlation between the increase in volume and the increase in length in this pig model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • In Vitro Techniques
  • Kidney / diagnostic imaging*
  • Kidney / drug effects
  • Kidney / pathology*
  • Magnetic Resonance Imaging / methods*
  • Organ Size / drug effects
  • Organ Size / physiology
  • Swine
  • Swine, Miniature
  • Time
  • Ultrasonography

Substances

  • Immunosuppressive Agents
  • Cyclosporine